AI assistant
Sending…
Ernexa Therapeutics Inc. — Director's Dealing 2016
Nov 7, 2016
35259_dirs_2016-11-07_358753b0-1c52-4aec-8ece-bee4fe34fc9c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NTN BUZZTIME INC (NTN)
CIK: 0000748592
Period of Report: 2016-11-04
Reporting Person: Wolff Allen (CFO and EVP)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-04 | Common Stock | A | 26000 | $6.64 | Acquired | 27910 | Direct |
| 2016-11-04 | Common Stock | A | 1750 | $6.64 | Acquired | 29660 | Indirect |
| 2016-11-04 | Common Stock | A | 1750 | $6.64 | Acquired | 31410 | Indirect |
Footnotes
F1: As custodian of Minor Child 1.
F2: As custodian of Minor Child 2.
More from Ernexa Therapeutics Inc.
Major Shareholding Notification
2026
May 14
Annual Report
2026
May 11
Proxy Solicitation & Information Statement
2026
May 11
Proxy Solicitation & Information Statement
2026
May 11
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 31
Registration Form
2026
Mar 24